Daré Bioscience Inc.

NASDAQ: DARE · Real-Time Price · USD
2.06
0.04 (1.98%)
At close: Aug 20, 2025, 3:59 PM
2.03
-1.55%
After-hours: Aug 20, 2025, 06:44 PM EDT

Daré Bioscience Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
-21.17K 25.43K -63.65K 41.69K 22.44K 9.3K 1.81M 1M n/a n/a 10B n/a 10M n/a n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a 9.74K 25K 7.67K 9.98K 9.26K 9.62K n/a 4.72K 3.03K 5.32K 5.23K 76.4K -17.74K 6.61K 6.41K
Gross Profit
-21.17K 25.43K -14.29M 31.95K -2.56K 1.63K 1.8M 990.74K -9.62K n/a 10B -3.03K 9.99M -5.23K -76.4K 17.74K -6.61K -6.41K
Operating Income
-3.83M -4.58M -5.39M -4.68M -7.36M -5.99M -5.17M -8.4M -8.99M -8.38M -16.23M -7.14M 384.32K -8.4M -9.54M -12.67M -9.16M -7.69M
Interest Income
69.85K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-4.02M -4.38M -5.51M -4.7M 12.91M -6.75M -5.06M -8.3M -8.76M -8.04M -15.94M -7.02M 414K -8.4M -9.54M -12.67M -9.16M -7.32M
Net Income
-4.02M -4.38M -5.51M -4.7M 12.91M -6.75M -5.06M -8.3M -8.76M -8.04M -15.94M -7.02M 414K -8.4M -9.54M -12.67M -9.16M -7.32M
Selling & General & Admin
2.38M 2.31M 2M 2.04M 2.47M 2.66M 2.95M 2.7M 2.92M 3.34M 3.23M 2.65M 2.79M 2.57M 2.4M 2.21M 1.8M 1.94M
Research & Development
1.43M 2.3M 3.31M 2.66M 4.91M 3.33M 3.8M 6.67M 6.04M 5.02M 12.98M 4.46M 6.8M 5.8M 7.12M 10.43M 7.34M 5.73M
Other Expenses
n/a 545.00 18K -228 n/a n/a 113.9K 25K n/a n/a 100K n/a 29.68K 1.78K 834.00 1.51K 175.00 3.00
Operating Expenses
3.81M 4.61M 5.33M 4.7M 7.38M 5.99M 6.94M 9.4M 8.99M 8.38M 16.23M 7.14M 9.62M 8.4M 9.54M 12.67M 9.16M 7.69M
Interest Expense
268.53K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a 215K 194K n/a -43.45K 191K 125K 145K 139K 131K 116K 150K 169K 141K 134K 151K 135K
Cost & Expenses
3.81M 4.61M 5.33M 4.72M 7.38M 6M 6.95M 9.4M 8.99M 8.38M 16.23M 7.14M 9.62M 8.4M 9.54M 12.67M 9.16M 7.69M
Income Tax Expense
n/a n/a n/a n/a n/a n/a -33.83K -9.26K n/a n/a n/a n/a n/a -1.78K -69.36K 24.09K n/a n/a
Shares Outstanding (Basic)
8.87M 8.76M 8.5M 8.53M 8.41M 8.38M 7.3M 7.59M 7.2M 7.13M 6.8M 7.07M 7.11M 7M 4.34M 4.27M 4.2M 3.71M
Shares Outstanding (Diluted)
8.87M 8.76M 8.5M 8.53M 8.48M 8.38M 7.3M 7.59M 7.2M 7.13M 6.8M 7.07M 7.11M 7M 4.34M 4.27M 4.2M 3.71M
EPS (Basic)
-0.45 -0.5 -0.65 -0.55 1.53 -0.81 -0.69 -1.09 -1.22 -1.13 -2.34 -0.98 0.06 -0.1 -0.13 -0.18 -0.18 -0.16
EPS (Diluted)
-0.45 -0.5 -0.65 -0.55 1.52 -0.81 -0.69 -1.09 -1.22 -1.13 -2.34 -0.98 0.06 -0.1 -0.13 -2.97 -0.18 -0.16
EBITDA
-3.37M -4.42M -5.38M -4.67M -7.34M -6.01M -5.16M -8.39M -8.98M -8.37M -16.22M -7.14M 389.64K -8.39M -9.54M -12.66M -9.16M -7.69M
EBIT
-3.83M -4.58M -5.39M -4.68M -7.36M -6.02M -5.06M -8.4M -8.99M -8.38M -16.23M -7.14M 384.32K -8.4M -9.54M -12.67M -9.16M -7.69M
Depreciation & Amortization
460.07K 158.11K 6.37K 9.74K 15.44K 10.78K 9.98K 9.26K 9.62K 9.51K 10.62K 3.03K 5.32K 5.23K 76.4K 6.34K 6.61K 6.41K